News + Filings Transactions Holdings
All 13F 13D/G Other
|
Birchview Capital, LP
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/08/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/12/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
03/27/2023 |
4
| Birchview Capital, LP (10% Owner) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns:
| Bought 100,000 shares
@ $1.491, valued at
$149.1k
Bought 10,000 shares
@ $1.491, valued at
$14.9k
Bought 18,000 shares
@ $1.3539, valued at
$24.4k
Bought 2,000 shares
@ $1.3539, valued at
$2.7k
Bought 10,000 shares
@ $1.587, valued at
$15.9k
|
|
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/03/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
12/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
11/28/2022 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
11/07/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/12/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/13/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
12/16/2021 |
SC 13G
| Birchview Capital, LP reports a 15.3% stake in AZIYO BIOLOGICS, INC. |
11/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/10/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/14/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/09/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/12/2020 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
11/12/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
09/25/2020 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
08/10/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/12/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/12/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/12/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/06/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/03/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
03/19/2019 |
SC 13G/A
| Birchview Capital, LP reports a 2.3% stake in SOLENO THERAPEUTICS INC. |
02/06/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/01/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/02/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/07/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/02/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
12/29/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
|
|
|